Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: A case report

Tumori

Volumn 95, Issue 4, 2009, Pages 553-556

  De Cicco, Luigi ^a   Vavassori, Andrea ^a   Cattani, Federica ^a   Jereczek Fossa, Barbara A ^a,b   Orecchia, Roberto ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

HDR brachytherapy; Prostate cancer; Reirradiation; Salvage therapy

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CASE REPORT; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN TISSUE; MALE; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; SALVAGE THERAPY; TREATMENT REFUSAL;

EID: 70350065503     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500429     Document Type: Article

References (23)

1. Lee WR, Hanks GE, Hanion A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol, 15: 230-238, 1997.
2. Tourna NJ, Izawa JI, Chin JL: Current status of local salvage therapies following radiation failure for prostate cancer. J Urol, 173: 373-379, 2005.
3. Beyer DC: Brachytherapy for recurrent prostate cancer after radiation therapy. Semin Radiat Oncol, 13: 158-165, 2003. (Pubitemid 36547493)
4. Allen GW, Howard AR, Jarrard DF, Ritter MA: Management of prostate cancer recurrences after radiation therapy - Brachytherapy as a salvage option. Cancer, 110: 1405-1416, 2007. (Pubitemid 47463053)
5. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ: Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol, 176: 2020-2024, 2006.
6. Lee HK, Adams MT, Motta J: Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy, 7: 17-21, 2008.
7. Lee B, Shinohara K, Weinberg V, Gottschalk AR, Pouliot J, Roach M 3rd, Hsu IC: Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys, 67: 1106-1112, 2007.
8. Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J: Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy, 7: 231-236, 2008.
9. American Society for Therapeutic Radiology and Oncology (ASTRO) Consensus Panel: Consensus Statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys, 37: 1035-1041, 1997.
10. Memorial Sloan-Kettering Cancer Center prostate nomogram - PSA Doubling Time. Available at http://www.mskcc.org (accessed 27 July, 2009).
11. Fowler J, Chappell R, Ritter M: Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys, 50: 1021-1031, 2001.
12. Brenner DJ, Hall EJ: Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys, 43: 1095-1101, 1999.
13. King CR, Fowler JF: A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys, 51: 213-214, 2001.
14. Lotan Y, Stanfield J, Cho LC, Sherwood JB, Abdel-Aziz KF, Chang CH, Forster K, Rabbani W, Hsieh JT, Choy H, Timmerman R: Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model. J Urol, 175: 1932-1936, 2006.
15. Wang JZ, Li XA, Yu CX, DiBiase SJ: The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys, 57: 1101-1108, 2003.
16. Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS: High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol, 171: 1098-1104, 2004. (Pubitemid 38327535)
17. Lloyd-Davies RW, Collins CD, Swan AV: Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology, 36: 107-111, 1990.
18. Kupelian PA, Reddy CA, Klein EA, Willoughby TR: Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys, 51: 988-993, 2001.
19. Fowler JF, Nahum AE, Orton CG: Point/Counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. Med Phys, 33: 3081-3084, 2006.
20. Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J: Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 133.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys, 67: 1099-1105, 2007. (Pubitemid 46320084)
21. Corner C, Rojas AM, Bryant L, Ostler P, Hoskin P: A phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys, 72: 441-446, 2008.
22. Yoshioka Y, Nose T, Yoshida K, Oh RJ, Yamada Y, Tanaka E, Yamazaki H, Inoue T, Inoue T: High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys, 56: 213-220, 2003. (Pubitemid 36403694)
23. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P: CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 13: 176-181, 2003. (Pubitemid 36962641)